Wharton, L.; McNeil, S.W.; Merkens, H.; Yuan, Z.; Van de Voorde, M.; Engudar, G.; Ingham, A.; Koniar, H.; RodrÃguez-RodrÃguez, C.; Radchenko, V.;
et al. Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours. Molecules 2023, 28, 3155.
https://doi.org/10.3390/molecules28073155
AMA Style
Wharton L, McNeil SW, Merkens H, Yuan Z, Van de Voorde M, Engudar G, Ingham A, Koniar H, RodrÃguez-RodrÃguez C, Radchenko V,
et al. Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours. Molecules. 2023; 28(7):3155.
https://doi.org/10.3390/molecules28073155
Chicago/Turabian Style
Wharton, Luke, Scott W. McNeil, Helen Merkens, Zheliang Yuan, Michiel Van de Voorde, Gokce Engudar, Aidan Ingham, Helena Koniar, Cristina RodrÃguez-RodrÃguez, Valery Radchenko,
and et al. 2023. "Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours" Molecules 28, no. 7: 3155.
https://doi.org/10.3390/molecules28073155
APA Style
Wharton, L., McNeil, S. W., Merkens, H., Yuan, Z., Van de Voorde, M., Engudar, G., Ingham, A., Koniar, H., RodrÃguez-RodrÃguez, C., Radchenko, V., Ooms, M., Kunz, P., Bénard, F., Schaffer, P., & Yang, H.
(2023). Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours. Molecules, 28(7), 3155.
https://doi.org/10.3390/molecules28073155
